IP Library Granted Patent US 7,795,019
Granted Patent B2
US 7,795,019 · App. 11/938,065 · Granted Sep 14, 2010

Stable cell lines and methods for evaluating gastrointestinal absorption of chemicals

Assignee: Absorption Systems Group, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,795,019
App. No.
11/938,065
Granted
Sep 14, 2010
Kind
B2
Abstract

Nucleic acids and vectors for interfering with the expression of membrane efflux transport proteins in cells that express such proteins are provided. Also provided are cells and cell lines comprising such nucleic acids and vectors. Methods for screening chemicals and biomolecules for gastrointestinal absorption in animals, and kits for practicing such methods are also provided.

Claims (11)

1. A host cell transformed with a vector comprising a nucleic acid sequence encoding a nucleic acid molecule for inhibiting expression of a membrane efflux transport protein, wherein the nucleic acid sequence comprises SEQ ID NO: 22, 23, 24, 25, or 26.

2. The host cell of claim 1 , wherein the cell expresses a membrane efflux transport protein.

3. The host cell of claim 1 , wherein the cell is an intestinal epithelial cell.

4. A cell culture comprising the host cell of claim 3 .

5. The host cell of claim 1 , wherein the membrane efflux transport protein is Breast Cancer Resistance Protein.

6. The host cell of claim 5 , wherein said host cell has been deposited with the American Type Culture Collection and assigned accession number PTA-8754 or PTA-8755.

7. A kit for determining the absorption characteristics of a chemical compound, comprising the cell of claim 1 .

8. The host cell of claim 1 , wherein the cell is a Caco-2 cell.

9. The host cell of claim 1 , wherein the cell is derived from a Caco-2 cell.

10. The host cell of claim 1 , wherein the cell is a C2BBe1 cell.

11. A vector comprising a nucleic acid sequence encoding a nucleic acid molecule for inhibiting expression of at least one membrane efflux transport protein, wherein the nucleic acid sequence comprises SEQ ID NO: 22, 23, 24, 25, or 26.

Assignments (4)
CHANGE OF NAME Recorded Aug 16, 2023
From: ABSORPTION SYSTEMS LLC
To: PHARMARON (EXTON) LAB SERVICES LLC
Reel/Frame 064615/0410 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2020
From: ABSORPTION SYSTEMS GROUP, LLC
To: ABSORPTION SYSTEMS LLC
Reel/Frame 052210/0520 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2020
From: ABSORPTION SYSTEMS GROUP, LLC
To: ABSORPTION SYSTEMS LLC
Reel/Frame 052098/0174 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2008
From: OWEN, ALBERT J., III; HIDALGO, ISMAEL J.; LI, JIBIN; ZHANG, WEI
To: ABSORPTION SYSTEMS GROUP, LLC
Reel/Frame 020378/0254 →
Continuity (3)
Provisional Application 6089266500 · Mar 2, 2007
Provisional Application 6085793800 · Nov 10, 2006
Related Publication 20080124734A1 · May 29, 2008